Reply to 'Fasting in oncology: a word of caution'

Alessio Nencioni^{1

2}, Irene Caffa¹, Salvatore Cortellino³, Valter D Longo^{4

5}

Affiliations

¹ Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
² IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
³ IFOM, FIRC Institute of Molecular Oncology, Milano, Italy.
⁴ IFOM, FIRC Institute of Molecular Oncology, Milano, Italy. vlongo@usc.edu.
⁵ Longevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA. vlongo@usc.edu.

Comment

Alessio Nencioni et al. Nat Rev Cancer. 2019 Mar.

. 2019 Mar;19(3):178.

doi: 10.1038/s41568-018-0100-x.

Alessio Nencioni^{1

2}, Irene Caffa¹, Salvatore Cortellino³, Valter D Longo^{4

5}

¹ Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
² IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
³ IFOM, FIRC Institute of Molecular Oncology, Milano, Italy.
⁴ IFOM, FIRC Institute of Molecular Oncology, Milano, Italy. vlongo@usc.edu.
⁵ Longevity Institute, Leonard Davis School of Gerontology and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA. vlongo@usc.edu.

No abstract available

Comment on

Fasting and cancer: molecular mechanisms and clinical application.
Nencioni A, Caffa I, Cortellino S, Longo VD. Nencioni A, et al. Nat Rev Cancer. 2018 Nov;18(11):707-719. doi: 10.1038/s41568-018-0061-0. Nat Rev Cancer. 2018. PMID: 30327499 Free PMC article. Review.
Fasting in oncology: a word of caution.
Caccialanza R, Aprile G, Cereda E, Pedrazzoli P. Caccialanza R, et al. Nat Rev Cancer. 2019 Mar;19(3):177. doi: 10.1038/s41568-018-0098-0. Nat Rev Cancer. 2019. PMID: 30651606 No abstract available.